山西医科大学学报2016，Vol.47Issue(10)：914-917,4.DOI:10.13753/j.issn.1007-6611.2016.10.008
化疗序贯EGFR-TKI治疗EGFR-TKI获得性耐药晚期NSCLC患者的临床观察
Clinical observation of chemotherapy sequential EGFR-TKI in treatment of advanced non-small cell lung cancer patients with EGFR-TKI acquired resistance
王紫润 1戈伟1
作者信息
- 1. 武汉大学人民医院肿瘤Ⅱ科,武汉430060
- 折叠
摘要
关键词
非小细胞肺癌/EGFR-TKI/获得性耐药/化疗Key words
non-small cell lung cancer (NSCLC)/epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)/acquired resistance/chemotherapy分类
医药卫生引用本文复制引用
王紫润,戈伟..化疗序贯EGFR-TKI治疗EGFR-TKI获得性耐药晚期NSCLC患者的临床观察[J].山西医科大学学报,2016,47(10):914-917,4.
